{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T05:51:28Z","timestamp":1781934688206,"version":"3.54.5"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Res Notes"],"DOI":"10.1186\/s13104-025-07428-4","type":"journal-article","created":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T17:58:25Z","timestamp":1756749505000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["CD4 cell count and viral load count association and its joint risk factors among adult TB\/HIV co-infected patients: a retrospective follow-up study"],"prefix":"10.1186","volume":"18","author":[{"given":"Nurye Seid","family":"Muhie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Awoke Seyoum","family":"Tegegne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,1]]},"reference":[{"key":"7428_CR1","unstructured":"World TB. Report 2021."},{"key":"7428_CR2","unstructured":"WHO launches. updated guidance on HIV-associated TB, 2024."},{"key":"7428_CR3","doi-asserted-by":"publisher","unstructured":"Golett ASF, Weissman D, Jackson RW, Graham NM, Vlahov D, Klein RS, Munsiff SS, Ortona L, Cauda R. Effect of Mycobacterium tuberculosis on HIV replication. Role of immune activation. J Immunol 1 August 1996; 157 (3): 1271\u20131278. , vol. 157, no. August, p. 642, 1996. https:\/\/doi.org\/10.4049\/jimmunol.157.3.1271","DOI":"10.4049\/jimmunol.157.3.1271"},{"key":"7428_CR4","doi-asserted-by":"publisher","unstructured":"Wejse B C et al., \u201cImpact of tuberculosis treatment on CD4 cell count, HIV RNA, and p24 antigen in patients with HIV and tuberculosis.\u201d International Journal of Infectious Diseases, 2013. https:\/\/doi.org\/10.1016\/j.ijid.2013.05.003","DOI":"10.1016\/j.ijid.2013.05.003"},{"key":"7428_CR5","doi-asserted-by":"crossref","unstructured":"Langford CDS, Ananworanich J. Predictors of disease progressionin HIVinfection: a review.AIDS Res Ther2007; 4:11., p. 2007, 2007.","DOI":"10.1186\/1742-6405-4-11"},{"issue":"8","key":"7428_CR6","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1086\/529523","volume":"197","author":"JD Lundgren","year":"2008","unstructured":"Lundgren JD, et al. Inferior clinical outcome of the CD4\u2009+\u2009cell count-guided antiretroviral treatment interruption strategy in the SMART study: role of CD4\u2009+\u2009cell counts and HIV RNA levels during follow-up. J Infect Dis. 2008;197(8):1145\u201355. https:\/\/doi.org\/10.1086\/529523","journal-title":"J Infect Dis"},{"key":"7428_CR7","doi-asserted-by":"publisher","unstructured":"Hussain, T., Kulshreshtha, K. K., Yadav, V. S., & Katoch, K. (2014). Cd4+, Cd8+, Cd3+ Cell Counts And Cd4+\/cd8+ Ratio Among Patients With Mycobacterial Diseases (leprosy, Tuberculosis), Hiv Infections, And Normal Healthy Adults: A Comparative Analysis Of Studies In Different Regions Of India. Journal of Immunoassay and Immunochemistry, 36(4), 420\u2013443. https:\/\/doi.org\/10.1080\/15321819.2014.978082","DOI":"10.1080\/15321819.2014.978082"},{"issue":"3","key":"7428_CR8","doi-asserted-by":"publisher","first-page":"185","DOI":"10.4103\/1817-1737.160838","volume":"10","author":"BM Musa","year":"2015","unstructured":"Musa BM, Musa B, Muhammed H, Ibrahim N, Musa AG. Incidence of tuberculosis and immunological profile of TB\/HIV co-infected patients in Nigeria. Ann Thorac Med. 2015;10(3):185\u201392. https:\/\/doi.org\/10.4103\/1817-1737.160838.","journal-title":"Ann Thorac Med"},{"issue":"5","key":"7428_CR9","doi-asserted-by":"publisher","first-page":"256","DOI":"10.2188\/jea.JE20210150","volume":"33","author":"F Kagiura","year":"2023","unstructured":"Kagiura F, et al. Trends in CD4\u2009+\u2009Cell counts, viral load, treatment, testing history, and sociodemographic characteristics of newly diagnosed HIV patients in osaka, japan, from 2003 through 2017: A descriptive study. J Epidemiol. 2023;33(5):256\u201361. https:\/\/doi.org\/10.2188\/jea.JE20210150.","journal-title":"J Epidemiol"},{"key":"7428_CR10","doi-asserted-by":"crossref","unstructured":"Sighem A, Nakagawa F, De Angelis D. Estimating HIV incidence, time to diagnosis, and the undiagnosed HIV epidemic using routine surveillance data. Epidemiology. 2015;26(5):653\u2013660., vol. 151, no. 5, pp. 10\u201317, 2015.","DOI":"10.1097\/EDE.0000000000000324"},{"key":"7428_CR11","doi-asserted-by":"crossref","unstructured":"Ingole SPN, Nataraj G, Mehta P, Paranjpe S. CD4\u2009+\u2009counts in laboratory monitoring of HIV disease\u2014 experience from Western India. J Int Assoc AIDS Care. 2014; 13 (4): 324-7., Tesis Dr., vol. 2014, no. June, pp. 1\u20132, 2014.","DOI":"10.1177\/2325957412474846"},{"key":"7428_CR12","doi-asserted-by":"crossref","unstructured":"Arafa KM, Rida SZ. Fractional modelling dyna_mics of HIV and CD4\u2009+\u2009T-cells during primary infection. Nonlinear Biomed Phys. 2012; 6 (1): 1\u20137, \u042d\u043a\u043e\u043d\u043e\u043c\u0438\u043a\u0430 \u0420\u0435\u0433\u0438\u043e\u043d\u0430, vol. 6, no. 1, p. 32, 2012.","DOI":"10.1186\/1753-4631-6-1"},{"key":"7428_CR13","doi-asserted-by":"crossref","unstructured":"Gaurav AN, Keerthilatha PM. Prevalence of oral manifestations and their association with CD4+\/CD8\u2009+\u2009ratio and HIV viral load in South India. Int J Dent. 2011; 2011: 1\u20135., p. 2011, 2011.","DOI":"10.1155\/2011\/964278"},{"issue":"4","key":"7428_CR14","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1097\/QAI.0b013e318246bfce","volume":"59","author":"MF Schneider","year":"2012","unstructured":"Schneider MF, Margolick JB, Jacobson LP, Reddy S, Al. Improved Estimation of the distribution of suppressed plasma HIV-1 RNA in men receiving effective antiretroviral therapy. J Acquir Immune Defic Syndr. 2012;59(4):389\u201397.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"6","key":"7428_CR15","doi-asserted-by":"publisher","first-page":"5950","DOI":"10.1371\/journal.pone.0005950","volume":"4","author":"DC Korenromp","year":"2009","unstructured":"Korenromp DC, Williams EL, Schmid BG. Clinical prognostic value of RNA viral load and CD4\u2009+\u2009cell counts during untreated HIV-1 infection\u2014a quantitative review. PLoS ONE. 2009;4(6):5950\u201361.","journal-title":"PLoS ONE"},{"issue":"3","key":"7428_CR16","doi-asserted-by":"publisher","first-page":"220","DOI":"10.4103\/jme.jme_141_22","volume":"4","author":"P Gupta","year":"2023","unstructured":"Gupta P, Tomar A, Bansal M, Gupta RK. Clinico-epidemiological determinants of tuberculosis Co-infection among adults attending an antiretroviral centre at a tertiary care hospital in Madhya Pradesh. J Med Evid. 2023;4(3):220\u20134. https:\/\/doi.org\/10.4103\/jme.jme_141_22.","journal-title":"J Med Evid"},{"issue":"1","key":"7428_CR17","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1097\/00002030-200401020-00006","volume":"18","author":"K Porter","year":"2004","unstructured":"Porter K, Phillips A. Short-term risk of AIDS according to current CD4 cell count and viral load in antiretroviral drug-naive individuals and those treated in the monotherapy era. AIDS. 2004;18(1):51\u20138. https:\/\/doi.org\/10.1097\/00002030-200401020-00006.","journal-title":"AIDS"},{"key":"7428_CR18","doi-asserted-by":"crossref","unstructured":"Goujard DC, Bonarek M, Meyer L, Bonnet F, Chaix ML, Al. E. CD4 cell count and HIV DNA level are independent predictors of disease progression after primary HIV type 1 infection in untreated patients.Clin Infect Dis 2006; 42:709\u2013715., p. 2006, 2006.","DOI":"10.1086\/500213"},{"key":"7428_CR19","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/S0140-6736(08)61113-7","volume":"372","author":"ATC Collaboration","year":"2008","unstructured":"Collaboration. ATC. Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies. Lancet. 2008;372:293\u20139. https:\/\/doi.org\/10.1016\/S0140-6736(08)61113-7.","journal-title":"Lancet"},{"issue":"1","key":"7428_CR20","doi-asserted-by":"publisher","first-page":"115","DOI":"10.22452\/jummec.vol26no1.17","volume":"26","author":"CA Paramadika","year":"2023","unstructured":"Paramadika CA, et al. Relationship between Cd4 levels, viral load, and the number of opportunistic infections among patients with Hiv infection at Sanglah general hospital. J Heal Transl Med. 2023;26(1):115\u201321. https:\/\/doi.org\/10.22452\/jummec.vol26no1.17.","journal-title":"J Heal Transl Med"},{"issue":"2","key":"7428_CR21","doi-asserted-by":"publisher","first-page":"88","DOI":"10.4314\/ahs.v23i2.10","volume":"23","author":"CU Obi","year":"2023","unstructured":"Obi CU, et al. Human growth hormone, a marker for HIV infection among adult Igbo nigerians: relationship between human growth hormone and CD4\u2009+\u2009count with viral load. Afr Health Sci. 2023;23(2):88\u201396. https:\/\/doi.org\/10.4314\/ahs.v23i2.10.","journal-title":"Afr Health Sci"},{"key":"7428_CR22","doi-asserted-by":"publisher","unstructured":"Wondmeneh TG, Mekonnen AT. The incidence rate of tuberculosis and its associated factors among HIV-positive persons in Sub-Saharan africa: a systematic review and meta-analysis. BMC Infect Dis. 2023;1\u201324. https:\/\/doi.org\/10.1186\/s12879-023-08533-0.","DOI":"10.1186\/s12879-023-08533-0"},{"key":"7428_CR23","doi-asserted-by":"publisher","unstructured":"Arnaot RA, Lloyd AL, T R O\u2019Brien J, Goedert JM, Leonard, Nowak MA. A simple relationship between viral load and survival time in HIV-1 infection, Proc. Natl. Acad. Sci. U. S. A., vol. 96, no. 20, pp. 11549\u201311553, 1999, https:\/\/doi.org\/10.1073\/pnas.96.20.11549","DOI":"10.1073\/pnas.96.20.11549"},{"key":"7428_CR24","doi-asserted-by":"crossref","unstructured":"Eleni Seyoum M, Demissie AW, Mulu A, Berhane Y, HIV\/AIDS -. Res Palliat Care. 2022;2022:14. https:\/\/doi.org\/10.2147\/HIV.S354436. Increased Mortality in HIV Infected Individualswith Tuberculosis: A Retrospective Cohort Study,Addis Ababa, Ethiopia,2022.","DOI":"10.2147\/HIV.S354436"},{"key":"7428_CR25","doi-asserted-by":"publisher","unstructured":"Katende-Kyenda LN. Relationship between CD4 count, viral load, and quality of life in HIV-infected patients on HAART attending a primary healthcare setting in South Africa. Am J Med Clin Res Rev. 2023;02(01). https:\/\/doi.org\/10.58372\/2835-6276.1019.","DOI":"10.58372\/2835-6276.1019"},{"key":"7428_CR26","doi-asserted-by":"crossref","unstructured":"Zhou J, Sirisanthana T, Kiertiburanakul S, Chen YM, Han N, Lim PL, Kumarasamy N, Choi JY, Merati TP, Yunihastuti E, Oka S, Kamarulzaman A, Phanuphak P, Lee CK, Li PC, Pujari S, Saphonn V, Law MG. Trends in CD4 counts in HIV-infected patients with HIV viral load monitoring while on combination antiretroviral treatment: results from The TREAT Asia HIV Observational Database. BMC Infect Dis. 2010 Dec 23;10:361. doi: 10.1186\/1471-2334-10-361. PMID: 21182796; PMCID: PMC3022834.","DOI":"10.1186\/1471-2334-10-361"},{"key":"7428_CR27","doi-asserted-by":"publisher","unstructured":"Niraula SR et al. Prevalence and CD4 Cell Count Pattern of TB Co-infection Among HIV Infected Individuals In Nepal, SAARC J. Tuberc. Lung Dis. HIV\/AIDS, vol. 10, no. 1, pp. 27\u201336, 2013, https:\/\/doi.org\/10.3126\/saarctb.v10i1.8674","DOI":"10.3126\/saarctb.v10i1.8674"},{"key":"7428_CR28","doi-asserted-by":"publisher","unstructured":"Birhan H, Seyoum A, Derebe K, Muche S, Wale M, Sisay S. Joint clinical and socio-demographic determinants of CD4 cell count and body weight in HIV\/TB co-infected adult patients on HAART, Sci. African, vol. 18, p. 2022, 2022. https:\/\/doi.org\/10.1016\/j.sciaf.2022.e01396","DOI":"10.1016\/j.sciaf.2022.e01396"},{"key":"7428_CR29","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1186\/s13104-024-06808-6","volume":"17","author":"NS Muhie","year":"2024","unstructured":"Muhie NS. Joint clinical determinants for bivariate hematological parameter among TB\/HIV co-infected adults under TB\/HIV treatment in university of Gondar comprehensive specialized hospital: retrospective panel data study. BMC Res Notes. 2024;17:150. https:\/\/doi.org\/10.1186\/s13104-024-06808-6.","journal-title":"BMC Res Notes"},{"key":"7428_CR30","doi-asserted-by":"crossref","unstructured":"Bayabil A, S., Seyoum, Joint Modeling in Detecting Predictors of CD4 Cell Count and Status of Tuberculosis Among People Living with HIV\/AIDS Under HAART at Felege Hiwot Teaching and Specialized Hospital, Ethiopia N-W. HIV\/AIDS - Research and Palliative Care, 13, 527\u2013537., vol. 4, no. 1, p. 6, 2021.","DOI":"10.2147\/HIV.S307069"},{"issue":"4","key":"7428_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2427\/13223","volume":"16","author":"B Alafchi","year":"2019","unstructured":"Alafchi B, Mahjub H, Tapak L, Poorolajal J, Roshanaei G. Modeling the trajectory of cd4 cell count and its effect on the risk of AIDS progression and Tb infection among hiv-infected patients using a joint model of competing risks and longitudinal ordinal data. Epidemiol Biostat Public Heal. 2019;16(4):1\u201311. https:\/\/doi.org\/10.2427\/13223.","journal-title":"Epidemiol Biostat Public Heal"},{"issue":"1","key":"7428_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12981-024-00625-4","volume":"21","author":"WG Ayana","year":"2024","unstructured":"Ayana WG, Ayana HM, Yadeta DA. Determinants of virologic failure among adult HIV patients on first line antiretroviral treatment in oromia, central ethiopia: 2022 a case-control study. AIDS Res Ther. 2024;21(1):1\u20137. https:\/\/doi.org\/10.1186\/s12981-024-00625-4.","journal-title":"AIDS Res Ther"},{"issue":"1","key":"7428_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-024-53569-0","volume":"14","author":"N Muhie","year":"2024","unstructured":"Muhie N, S. Predictors for viral load suppression among HIV positive adults under ART treatment in university of Gondar comprehensive specialized hospital: retrospective cohort study. Sci Rep. 2024;14(1):1\u201310. https:\/\/doi.org\/10.1038\/s41598-024-53569-0.","journal-title":"Sci Rep"},{"key":"7428_CR34","doi-asserted-by":"publisher","unstructured":"Linger M. Change in viral load count and its predictors among unsuppressed viral load patients receiving an enhanced adherence counseling intervention at three hospitals in Northern change in viral load count and its predictors among unsuppressed viral load patient, 2020, https:\/\/doi.org\/10.2147\/HIV.S283917","DOI":"10.2147\/HIV.S283917"},{"key":"7428_CR35","doi-asserted-by":"publisher","unstructured":"Moolasart V, et al. The effect of detectable Hiv viral load among Hiv-infected children during antiretroviral treatment: A cross-sectional study. Children. 2018;5(1). https:\/\/doi.org\/10.3390\/children5010006.","DOI":"10.3390\/children5010006"},{"key":"7428_CR36","doi-asserted-by":"publisher","first-page":"239","DOI":"10.2147\/HIV.S291872","volume":"13","author":"GM Ayana","year":"2021","unstructured":"Ayana GM, Akalu TY, Ayele TA. Joint modeling of incidence of tuberculosis and change in viral load over time among adult hiv\/ Mycobacterium tuberculosis patients on anti-retroviral therapy at Zewditu memorial hospital in addis ababa, Ethiopia. HIV\/AIDS - Res Palliat Care. 2021;13:239\u201349. https:\/\/doi.org\/10.2147\/HIV.S291872.","journal-title":"HIV\/AIDS - Res Palliat Care"},{"key":"7428_CR37","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1186\/s13104-023-06625-3","volume":"16","author":"NS Muhie","year":"2023","unstructured":"Muhie NS, Tegegne AS. Predictors for CD4 cell count and hemoglobin level with survival time to default for HIV positive adults under ART treatment at university of Gondar comprehensive and specialized hospital, Ethiopia. BMC Res Notes. 2023;16:357. https:\/\/doi.org\/10.1186\/s13104-023-06625-3.","journal-title":"BMC Res Notes"},{"issue":"1","key":"7428_CR38","doi-asserted-by":"publisher","first-page":"14929","DOI":"10.1038\/s41598-024-62952-w","volume":"14","author":"NS Muhie","year":"2024","unstructured":"Muhie NS, Tegegne AS. Determinants of hemoglobin level and time to default from highly active antiretroviral therapy (HAART) for adult clients living with HIV under treatment; a retrospective cohort study design. Sci Rep. 2024;14(1):14929. https:\/\/doi.org\/10.1038\/s41598-024-62952-w.","journal-title":"Sci Rep"},{"key":"7428_CR39","unstructured":"Psych E\/, Soc, Anderson CJ. Longitudinal Data Analysis via Linear Mixed Models - Edps\/Psych\/Soc 587, 2021, [Online]. Available: http:\/\/tigger.uic.edu\/"},{"issue":"1","key":"7428_CR40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12879-020-04972-1","volume":"20","author":"ZG Dessie","year":"2020","unstructured":"Dessie ZG, Zewotir T, Mwambi H, North D. Modelling of viral load dynamics and CD4 cell count progression in an antiretroviral Naive cohort: using a joint linear mixed and multistate Markov model. BMC Infect Dis. 2020;20(1):1\u201314. https:\/\/doi.org\/10.1186\/s12879-020-04972-1.","journal-title":"BMC Infect Dis"},{"key":"7428_CR41","doi-asserted-by":"publisher","unstructured":"Zhang Z, Guan C, Chen B, Xie R. Correlation between CD4 cell count, HIV viral load, and chest CT findings of AIDS-associated pulmonary cryptococcosis. Iran J Radiol. 2022;19(3). https:\/\/doi.org\/10.5812\/iranjradiol-127182.","DOI":"10.5812\/iranjradiol-127182"},{"key":"7428_CR42","doi-asserted-by":"publisher","unstructured":"Hantalo AH, Shano AK, Meja TI. Correlation of CD4\u2009+\u2009count and viral load with urinary tract infection and antimicrobial resistance pattern of bacterial uropathogens among HIV patients in Wolaita sodo, South Ethiopia. Front Microbiol. 2024;15. https:\/\/doi.org\/10.3389\/fmicb.2024.1363287.","DOI":"10.3389\/fmicb.2024.1363287"},{"issue":"2","key":"7428_CR43","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1182\/blood-2011-02-335174","volume":"118","author":"S Srinivasula","year":"2011","unstructured":"Srinivasula S, et al. Differential effects of HIV viral load and CD4 count on proliferation of Naive and memory CD4 and CD8 T lymphocytes. Blood. 2011;118(2):262\u201370. https:\/\/doi.org\/10.1182\/blood-2011-02-335174.","journal-title":"Blood"},{"issue":"1","key":"7428_CR44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12879-019-3781-1","volume":"19","author":"C Shoko","year":"2019","unstructured":"Shoko C, Chikobvu D. A superiority of viral load over CD4 cell count when predicting mortality in HIV patients on therapy. BMC Infect Dis. 2019;19(1):1\u201310. https:\/\/doi.org\/10.1186\/s12879-019-3781-1.","journal-title":"BMC Infect Dis"},{"key":"7428_CR45","doi-asserted-by":"publisher","unstructured":"Young J, et al. CD4 cell count and the risk of AIDS or death in HIV-infected adults on combination antiretroviral therapy with a suppressed viral load: A longitudinal cohort study from COHERE. PLoS Med. 2012;9(3). https:\/\/doi.org\/10.1371\/journal.pmed.1001194.","DOI":"10.1371\/journal.pmed.1001194"},{"key":"7428_CR46","doi-asserted-by":"publisher","unstructured":"Bekele AA, Tegegne AS, Muhie NS. Determinants Associated With CD4 Cell Count and Disclosure Status Among First-Line Antiretroviral Therapy Patients Treated at Felege Hiwot Comprehensive Specialized Hospital, Ethiopia, Journal of Tropical Medicine, 2025, 5989447, 12 pages, 2025. https:\/\/doi.org\/10.1155\/jotm\/5989447","DOI":"10.1155\/jotm\/5989447"},{"key":"7428_CR47","doi-asserted-by":"publisher","unstructured":"Gwadu AA, Tegegne MA, Mihretu KB, Tegegne AS. Predictors of Viral Load Status Over Time Among HIV Infected Adults Under HAART in Zewditu Memorial Hospital, Ethiopia: A Retrospective Study, HIV\/AIDS - Res. Palliat. Care, vol. 15, no. February, pp. 29\u201340, 2023, https:\/\/doi.org\/10.2147\/HIV.S396030","DOI":"10.2147\/HIV.S396030"},{"key":"7428_CR48","doi-asserted-by":"publisher","first-page":"29","DOI":"10.2147\/HIV.S396030","volume":"15","author":"AA Gwadu","year":"2023","unstructured":"Gwadu AA, Tegegne MA, Mihretu KB, Tegegne AS. Predictors of viral load status over time among HIV infected adults under HAART in Zewditu memorial hospital, ethiopia: A retrospective study. HIV\/AIDS - Res Palliat Care. 2023;15:29\u201340. https:\/\/doi.org\/10.2147\/HIV.S396030.","journal-title":"HIV\/AIDS - Res Palliat Care"},{"key":"7428_CR49","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1186\/s12879-022-07450-y","volume":"22","author":"AD Knudsen","year":"2022","unstructured":"Knudsen AD, Bouazzi R, Afzal S, et al. Monocyte count and soluble markers of monocyte activation in people living with HIV and uninfected controls. BMC Infect Dis. 2022;22:451. https:\/\/doi.org\/10.1186\/s12879-022-07450-y.","journal-title":"BMC Infect Dis"},{"key":"7428_CR50","doi-asserted-by":"publisher","unstructured":"Muhie, NS, Yimam, HM, Tegegne, AS, Bekele, AS, Clinical Determinants Associated With Viral Load Count Among Adult TB\/HIV Co-Infected Patients: A Linear Mixed-Effects Model Analysis, Advances in Virology, 2025, 4514560, 10 pages, 2025. https:\/\/doi.org\/10.1155\/av\/4514560","DOI":"10.1155\/av\/4514560"},{"key":"7428_CR51","doi-asserted-by":"publisher","first-page":"15348","DOI":"10.1038\/s41598-025-00033-2","volume":"15","author":"NS Muhie","year":"2025","unstructured":"Muhie NS, Tegegne AS. Survival analysis and predictors for hemoglobin level and time-to-default from HIV treatment among first-line female HIV-positive patients within the reproductive age group. Sci Rep. 2025;15:15348. https:\/\/doi.org\/10.1038\/s41598-025-00033-2.","journal-title":"Sci Rep"},{"key":"7428_CR52","doi-asserted-by":"publisher","unstructured":"Muhie NS, Rate I. Survival Rate, and Predictors for Virological Failure Among Adult TB\/HIV Coinfected Clients, Journal of Tropical Medicine, 2025, 2011556, 11 pages, 2025. https:\/\/doi.org\/10.1155\/jotm\/2011556","DOI":"10.1155\/jotm\/2011556"},{"key":"7428_CR53","doi-asserted-by":"publisher","unstructured":"Muhie NS. Common Risk Factors for CD4 Cell Count and Hemoglobin Level among Female Adult HIV-Positive Patients: A Retrospective Longitudinal Study, Journal of Tropical Medicine, 2024, 8461788, 10 pages, 2024. https:\/\/doi.org\/10.1155\/2024\/8461788","DOI":"10.1155\/2024\/8461788"},{"issue":"6","key":"7428_CR54","doi-asserted-by":"publisher","first-page":"e70867","DOI":"10.1002\/hsr2.70867","volume":"8","author":"NS Muhie","year":"2025","unstructured":"Muhie NS, Bekele AA, Tegegne AS. Predictors of longitudinal viral load count and survival time to death among adult TB\/HIV coinfected patients treated at two selected Amhara region comprehensive specialized hospitals, Ethiopia. Health Sci Rep. 2025;8(6):e70867. https:\/\/doi.org\/10.1002\/hsr2.70867. PMID: 40535517; PMCID: PMC12174616.","journal-title":"Health Sci Rep"},{"key":"7428_CR55","doi-asserted-by":"crossref","unstructured":"Tilahun M et al. Immuno-Haematological Abnormalities of HIV-Infected Patients Before and After Initiation of Highly Active Antiretroviral Therapy in the Antiretroviral Therapy Clinics of Six Health Facilities at Dessie Town, Northeast Ethiopia, no. May, pp. 243\u2013253, 2022.","DOI":"10.2147\/JBM.S364700"}],"container-title":["BMC Research Notes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13104-025-07428-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13104-025-07428-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13104-025-07428-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T01:59:49Z","timestamp":1757469589000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcresnotes.biomedcentral.com\/articles\/10.1186\/s13104-025-07428-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,1]]},"references-count":55,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["7428"],"URL":"https:\/\/doi.org\/10.1186\/s13104-025-07428-4","relation":{},"ISSN":["1756-0500"],"issn-type":[{"value":"1756-0500","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,1]]},"assertion":[{"value":"9 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"A statement to confirm that all methods were performed by the ethical standards as laid down in the Declaration of Helsinki. Hence, informed consent was waived by the Bahir Dar University research technical and ethical review board with Ref.no Stat-S\/166\/2022 because of the retrospective nature of the study. The study was approved by the Bahir Dar University Research Technical and Ethical Review Board.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"377"}}